These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34565739)

  • 1. POMT1 and POMT2 gene mutations result in 2 cases of
    Gan S; Yang H; Xiao T; Pan Z; Wu L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 46(8):915-919. PubMed ID: 34565739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.
    Godfrey C; Clement E; Mein R; Brockington M; Smith J; Talim B; Straub V; Robb S; Quinlivan R; Feng L; Jimenez-Mallebrera C; Mercuri E; Manzur AY; Kinali M; Torelli S; Brown SC; Sewry CA; Bushby K; Topaloglu H; North K; Abbs S; Muntoni F
    Brain; 2007 Oct; 130(Pt 10):2725-35. PubMed ID: 17878207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. POMT2 intragenic deletions and splicing abnormalities causing congenital muscular dystrophy with mental retardation.
    Yanagisawa A; Bouchet C; Quijano-Roy S; Vuillaumier-Barrot S; Clarke N; Odent S; Rodriguez D; Romero NB; Osawa M; Endo T; Taratuto AL; Seta N; Guicheney P
    Eur J Med Genet; 2009; 52(4):201-6. PubMed ID: 19138766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiomyopathy in patients with POMT1-related congenital and limb-girdle muscular dystrophy.
    Bello L; Melacini P; Pezzani R; D'Amico A; Piva L; Leonardi E; Torella A; Soraru G; Palmieri A; Smaniotto G; Gavassini BF; Vianello A; Nigro V; Bertini E; Angelini C; Tosatto SC; Pegoraro E
    Eur J Hum Genet; 2012 Dec; 20(12):1234-9. PubMed ID: 22549409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. POMT1 and POMT2 mutations in CMD patients: a multicentric Italian study.
    Messina S; Mora M; Pegoraro E; Pini A; Mongini T; D'Amico A; Pane M; Aiello C; Bruno C; Biancheri R; Berardinelli A; Boito C; Farina L; Morandi L; Moroni I; Pezzani R; Pichiecchio A; Ricci E; Ruggieri A; Saredi S; Scuderi C; Tessa A; Toscano A; Tortorella G; Trevisan CP; Uggetti C; Santorelli FM; Bertini E; Mercuri E
    Neuromuscul Disord; 2008 Jul; 18(7):565-71. PubMed ID: 18513969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expanding phenotype of POMT1 mutations: from Walker-Warburg syndrome to congenital muscular dystrophy, microcephaly, and mental retardation.
    van Reeuwijk J; Maugenre S; van den Elzen C; Verrips A; Bertini E; Muntoni F; Merlini L; Scheffer H; Brunner HG; Guicheney P; van Bokhoven H
    Hum Mutat; 2006 May; 27(5):453-9. PubMed ID: 16575835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New POMT2 mutations causing congenital muscular dystrophy: identification of a founder mutation.
    Yanagisawa A; Bouchet C; Van den Bergh PY; Cuisset JM; Viollet L; Leturcq F; Romero NB; Quijano-Roy S; Fardeau M; Seta N; Guicheney P
    Neurology; 2007 Sep; 69(12):1254-60. PubMed ID: 17634419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variations and clinical spectrum of dystroglycanopathy in a large cohort of Chinese patients.
    Song D; Dai Y; Chen X; Fu X; Chang X; Wang N; Zhang C; Yan C; Zheng H; Wu L; Jiang L; Hua Y; Yang H; Wang Z; Dai T; Zhu W; Han C; Yuan Y; Kobayashi K; Toda T; Xiong H
    Clin Genet; 2021 Mar; 99(3):384-395. PubMed ID: 33200426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compound heterozygous POMT1 mutations in a Chinese family with autosomal recessive muscular dystrophy-dystroglycanopathy C1.
    Hu P; Wu S; Yuan L; Lin Q; Zheng W; Xia H; Xu H; Guan L; Deng H
    J Cell Mol Med; 2017 Jul; 21(7):1388-1393. PubMed ID: 28157257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal muscle MRI of the lower limbs in congenital muscular dystrophy patients with novel POMT1 and POMT2 mutations.
    Hafner P; Bonati U; Fischmann A; Schneider J; Frank S; Morris-Rosendahl DJ; Dumea A; Heinimann K; Fischer D
    Neuromuscul Disord; 2014 Apr; 24(4):321-4. PubMed ID: 24556424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fukuyama congenital muscular dystrophy and related alpha-dystroglycanopathies].
    Murakami T; Nishino I
    Brain Nerve; 2008 Oct; 60(10):1159-64. PubMed ID: 18975603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fourth case of POMT2-related limb girdle muscle dystrophy with mild reduction of α-dystroglycan glycosylation.
    Saredi S; Gibertini S; Ardissone A; Fusco I; Zanotti S; Blasevich F; Morandi L; Moroni I; Mora M
    Eur J Paediatr Neurol; 2014 May; 18(3):404-8. PubMed ID: 24183756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dystroglycanopathy with two novel POMT1 mutations in a Chinese boy with developmental delay and muscular dystrophy.
    Chong YK; Ma LC; Lo KL; Lee CK; Mak CM; Kan AN; Lam CW
    Eur J Paediatr Neurol; 2014 Jul; 18(4):532-5. PubMed ID: 24657014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. POMGnT1, POMT1, and POMT2 mutations in congenital muscular dystrophies.
    Endo T; Manya H; Seta N; Guicheney P
    Methods Enzymol; 2010; 479():343-52. PubMed ID: 20816175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel POMT2 mutation causes mild congenital muscular dystrophy with normal brain MRI.
    Murakami T; Hayashi YK; Ogawa M; Noguchi S; Campbell KP; Togawa M; Inoue T; Oka A; Ohno K; Nonaka I; Nishino I
    Brain Dev; 2009 Jun; 31(6):465-8. PubMed ID: 18804929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study.
    Mercuri E; Messina S; Bruno C; Mora M; Pegoraro E; Comi GP; D'Amico A; Aiello C; Biancheri R; Berardinelli A; Boffi P; Cassandrini D; Laverda A; Moggio M; Morandi L; Moroni I; Pane M; Pezzani R; Pichiecchio A; Pini A; Minetti C; Mongini T; Mottarelli E; Ricci E; Ruggieri A; Saredi S; Scuderi C; Tessa A; Toscano A; Tortorella G; Trevisan CP; Uggetti C; Vasco G; Santorelli FM; Bertini E
    Neurology; 2009 May; 72(21):1802-9. PubMed ID: 19299310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Milder phenotype of congenital muscular dystrophy in a novel POMT1 mutation.
    Al-Zaidy SA; Baskin B; Hawkins C; Yoon G; Ray PN; Vajsar J
    Muscle Nerve; 2012 May; 45(5):752-5. PubMed ID: 22499106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetics of the POMT1-related muscular dystrophy-dystroglycanopathies.
    Hu P; Yuan L; Deng H
    Mutat Res Rev Mutat Res; 2018; 778():45-50. PubMed ID: 30454682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Congenital muscular dystrophy and alpha-dystroglycanopathy].
    Saito F; Matsumura K; Hagiwara H; Shimizu T
    Rinsho Shinkeigaku; 2008 Aug; 48(8):543-9. PubMed ID: 18939472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel cardiovascular findings in association with a POMT2 mutation: three siblings with α-dystroglycanopathy.
    Martinez HR; Craigen WJ; Ummat M; Adesina AM; Lotze TE; Jefferies JL
    Eur J Hum Genet; 2014 Apr; 22(4):486-91. PubMed ID: 24002165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.